Detalles de la búsqueda
1.
CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma.
Blood;
142(18): 1543-1555, 2023 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37562004
2.
Recent advances in the pharmacological targeting of ubiquitin-regulating enzymes in cancer.
Semin Cell Dev Biol;
132: 213-229, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35184940
3.
Distinct roles for PARP-1 and PARP-2 in c-Myc-driven B-cell lymphoma in mice.
Blood;
139(2): 228-239, 2022 01 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34359075
4.
Histone Modifications and Their Targeting in Lymphoid Malignancies.
Int J Mol Sci;
23(1)2021 Dec 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35008680
5.
Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual disease.
Br J Haematol;
191(1): 52-61, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32510599
6.
Daratumumab displays in vitro and in vivo anti-tumor activity in models of B-cell non-Hodgkin lymphoma and improves responses to standard chemo-immunotherapy regimens.
Haematologica;
105(4): 1032-1041, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31296574
7.
Loss of the Immune Checkpoint CD85j/LILRB1 on Malignant Plasma Cells Contributes to Immune Escape in Multiple Myeloma.
J Immunol;
200(8): 2581-2591, 2018 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29531171
8.
Resistance to the Proteasome Inhibitors: Lessons from Multiple Myeloma and Mantle Cell Lymphoma.
Adv Exp Med Biol;
1233: 153-174, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32274756
9.
Pharmacological modulation of CXCR4 cooperates with BET bromodomain inhibition in diffuse large B-cell lymphoma.
Haematologica;
104(4): 778-788, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29954928
10.
ZEB1-induced tumourigenesis requires senescence inhibition via activation of DKK1/mutant p53/Mdm2/CtBP and repression of macroH2A1.
Gut;
66(4): 666-682, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27965283
11.
Dual targeting of MCL1 and NOXA as effective strategy for treatment of mantle cell lymphoma.
Br J Haematol;
177(4): 557-561, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28295185
12.
Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation.
Haematologica;
107(12): 2990, 2022 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36453521
13.
The BET bromodomain inhibitor CPI203 improves lenalidomide and dexamethasone activity in in vitro and in vivo models of multiple myeloma by blockade of Ikaros and MYC signaling.
Haematologica;
102(10): 1776-1784, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28751557
14.
Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation.
Haematologica;
106(10): 2749-2753, 2021 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33979991
15.
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.
Proc Natl Acad Sci U S A;
110(45): 18250-5, 2013 Nov 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-24145436
16.
AduPARE1A and gemcitabine combined treatment trigger synergistic antitumor effects in pancreatic cancer through NF-κB mediated uPAR activation.
Mol Cancer;
14: 146, 2015 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-26227809
17.
SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma.
Blood;
121(12): 2175-85, 2013 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-23321250
18.
B cell activation through CD40 and IL4R ligation modulates the response of chronic lymphocytic leukaemia cells to BAFF and APRIL.
Br J Haematol;
164(4): 570-8, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24245956
19.
In vivo intratumoral Epstein-Barr virus replication is associated with XBP1 activation and early-onset post-transplant lymphoproliferative disorders with prognostic implications.
Mod Pathol;
27(12): 1599-611, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24762547
20.
Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy.
Cancer Res Commun;
4(2): 365-377, 2024 02 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38300528